Skip to main content
. 2022 Feb;84(1):169–179. doi: 10.18999/nagjms.84.1.169

Table 3.

Background characteristics of 8-week responders and non-responders

Variable Responder Non-responder P-value
N 8 10
Male/ Female 4/4 8/2 0.32
Age, median ± range 39 ± 15 33 ± 15 0.35
Body weight, kg, median ± range 54 ± 11 56 ± 7 0.62
Disease duration (month), median ± range 60 ± 48 54 ± 54 0.43
Disease type: Extensive/ left-sided 5/3 9/1 0.27
In-patient/ out-patient 2/6 8/2 0.05
History of emergency hospitalization, mean times 1.9 1.1 0.05
Lichtiger index ± SD 8.4 ± 1.4 8.1 ± 2.1 0.55
UCEIS 5.5 ± 0.8 5.4 ± 1.3 0.68
Hemoglobin (g/dL) 12.7 ± 2.0 10.3 ± 1.5 0.01
Albumin (g/dL) 3.6 ± 0.6 3.1 ± 0.7 0.09
C-reactive protein (mg/dL) 0.3 ± 0.6 1.8 ± 1.5 <0.01
Corticosteroid: Dependent/ refractory 3/5 5/5 0.99
Use of immunomodulator/ non-use 2/6 2/8 0.99
Previous biologics failure/ naïve 6/2 9/1 0.55
Previous biologics double or triple failure/ single failure or naïve 2/6 7/3 0.15
Previous calcineurin inhibitor failure/ naïve 1/7 7/3 0.02